ID
31029
Beskrivning
Study ID: 104505 Clinical Study ID: BEX104505 Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00950755 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin Please record all prior radiation therapies for NHL.
Nyckelord
Versioner (1)
- 2018-07-12 2018-07-12 -
Rättsinnehavare
see clinicaltrials.gov
Uppladdad den
12 juli 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755
Prior Radiation Therapy
- StudyEvent: ODM
Beskrivning
Prior Radiation Therapy
Alias
- UMLS CUI-1
- C1522449
- UMLS CUI-2
- C0332152
Beskrivning
Radiation Therapy Start Date
Datatyp
date
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C0808070
Beskrivning
Radiation Therapy, End Date
Datatyp
date
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C0806020
Beskrivning
radiation therapy pattern total dose
Datatyp
float
Måttenheter
- cGy
Alias
- UMLS CUI [1]
- C2169193
Beskrivning
Radiotherapy, irradiation site
Datatyp
text
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C2169202
Beskrivning
Radiotherapy, Outcome of Therapy
Datatyp
text
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C1518681
Similar models
Prior Radiation Therapy
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0332152 (UMLS CUI-2)
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C2169202 (UMLS CUI [1,2])
C1518681 (UMLS CUI [1,2])